Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
Michael G. Gartside(Translational Genomics Research Institute), Pamela M. Pollock(Translational Genomics Research Institute)
Cited by 118
Related Papers
PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers
|Molecular Cancer Therapeutics|2017|51
Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status
|Molecular Cancer|2012|45
FGFR2-activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer cell models
|Journal of Cell Science|2018|25